Related Experiment Video

Updated: Jun 6, 2026

Assay Development for High-Throughput Drug Screening Against Mycobacteria
07:50

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

Ceftaroline fosamil: a novel broad-spectrum cephalosporin

J A Bazan1, S I Martin

  • 1Division of Infectious Diseases, The Ohio State University Medical Center, Columbus, Ohio, USA. stanley.martin@osumc.edu

Drugs of Today (Barcelona, Spain : 1998)
|November 16, 2010
PubMed

Insights

Ceftaroline fosamil shows promise as a new antibiotic effective against resistant bacteria like MRSA. Clinical trials demonstrate its efficacy and good tolerability for treating serious infections.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Microbiology

Background:

  • The rise of antibiotic resistance, particularly from Gram-positive pathogens like methicillin-resistant Staphylococcus aureus (MRSA), poses a significant public health threat.
  • Existing antibiotic options are often limited in their effectiveness against these resistant strains.
  • There is a critical need for novel antimicrobial agents with broad-spectrum activity.

Purpose of the Study:

  • To evaluate the efficacy and safety of ceftaroline fosamil, a novel extended-spectrum cephalosporin.
  • To assess its activity against key drug-resistant Gram-positive and Gram-negative pathogens.
  • To review its therapeutic potential in various infection models and clinical settings.

Main Methods:

  • In vitro susceptibility testing against resistant pathogens.
  • In vivo efficacy studies in animal models for infections like endocarditis and pneumonia.
  • Phase II and III clinical trials in humans for skin/soft tissue infections and community-acquired pneumonia.

Main Results:

  • Ceftaroline fosamil demonstrated broad-spectrum activity, including against MRSA and penicillin-resistant Streptococcus pneumoniae.
  • In vivo studies showed efficacy in treating experimental infections.
  • Clinical trials confirmed efficacy in complicated skin and soft tissue infections and community-acquired pneumonia with a favorable safety profile.

Conclusions:

  • Ceftaroline fosamil is a well-tolerated antibiotic with demonstrated efficacy against challenging Gram-positive and Gram-negative pathogens.
  • It represents a significant advancement in treating infections caused by drug-resistant bacteria, including MRSA.
  • Upon FDA approval, it will offer a crucial new therapeutic option for clinicians.

More Related Videos

Antibiotic Dereplication Using the Antibiotic Resistance Platform10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

Isolation of Lipoprotein Particles from Chicken Egg Yolk for the Study of Bacterial Pathogen Fatty Acid Incorporation into Membrane Phospholipids11:59

Isolation of Lipoprotein Particles from Chicken Egg Yolk for the Study of Bacterial Pathogen Fatty Acid Incorporation into Membrane Phospholipids

Published on: May 15, 2019

Related Concept Videos

Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...